• 1.

    O'Brien PJ, Cribb PH, White RJ, et al. Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony. Can Vet J 1983; 24:172177.

    • Search Google Scholar
    • Export Citation
  • 2.

    Niedfeldt RL, Robertson SA. Postanesthetic hyperthermia in cats: a retrospective comparison between hydromorphone and buprenorphine. Vet Anaesth Analg 2006; 33:381389.

    • Search Google Scholar
    • Export Citation
  • 3.

    Posner LP, Gleed RD, Erb HN, et al. Post-anesthetic hyperthermia in cats. Vet Anaesth Analg 2007; 34:4047.

  • 4.

    Brunson DB, Hogan KJ. Malignant hyperthermia: a syndrome not a disease. Vet Clin North Am Small Anim Pract 2004; 34:14191433.

  • 5.

    Kirmayer AH, Klide AM, Purvance JE. Malignant hyperthermia in a dog: case report and review of the syndrome. J Am Vet Med Assoc 1984; 185:978982.

    • Search Google Scholar
    • Export Citation
  • 6.

    Grinberg R, Edelist G, Gordon A. Postoperative malignant hyperthermia in patients who received “safe” anesthesia. Can Anaesth Soc J 1983; 30:273276.

    • Search Google Scholar
    • Export Citation
  • 7.

    Wingard DW, Gatz EE. Some observations on stress susceptible patients, in Proceedings. 2nd Int Symp Malig Hyperthermia 1978;363372.

  • 8.

    Gronert GA, Thompson RL, Orofio BM. Human malignant hyperthermia-awake episode and correction with dantrolene. Anesth Analg 1980; 59:377378.

    • Search Google Scholar
    • Export Citation
  • 9.

    Hall GM, Bendall JR, Lucke JN, et al. Porcine malignant hyperthermia. II. Heat production. Br J Anaesth 1976; 48:305307.

  • 10.

    Roberts MC, Mickelson JR, Patterson EE, et al. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel. Anesthesiology 2001; 95:716725.

    • Search Google Scholar
    • Export Citation
  • 11.

    Nelson TE. Malignant hyperthermia in dogs. J Am Vet Med Assoc 1991; 198:989994.

  • 12.

    O'Brien PJ, Pook HA, Klip A, et al. Canine stress syndrome/malignant hyperthermia susceptibility: calcium homeostasis defect in muscle and lymphocytes. Res Vet Sci 1990; 48:124128.

    • Search Google Scholar
    • Export Citation
  • 13.

    Manley SV, McDonell WN. A new circuit for small animal anesthesia: the Bain coaxial system. J Am Anim Hosp Assoc 1979; 82:6673.

  • 14.

    Manley SV, McDonell WN. Clinical evaluation of Bain breathing circuit in small animal anesthesia. J Am Anim Hosp Assoc 1979; 15:6772.

  • 15.

    Roewer N, Dziadzka A, Greim CA, et al. Cardiovascular and metabolic responses to anesthetic-induced malignant hyperthermia in swine. Anesthesiology 1995; 83:141159.

    • Search Google Scholar
    • Export Citation
  • 16.

    Dibartola SP, Morais HA. Disorders of potassium: hypokalemia and hyperkalemia. In: Dibartola SP, ed. Fluid, electrolyte, and acid-base disorders in small animal practice. 3rd ed. Philadelphia: Elsevier Inc, 2006;91121.

    • Search Google Scholar
    • Export Citation
  • 17.

    Gronert GA. Malignant hyperthermia. Anaesthesia 1980; 53:395425.

  • 18.

    Britt BA. Etiology and pathophysiology of malignant hyperthermia. Fed Proc 1979; 38:4448.

  • 19.

    Snoeck MM, Gielen MJ, Tangerman A, et al. Contractures in skeletal muscle of malignant hyperthermia susceptible patients after in vitro exposure to sevoflurane. Acta Anaesthesiol Scand 2000; 44:334337.

    • Search Google Scholar
    • Export Citation
  • 20.

    Claussen D, Wuttig K, Freudenberg J, et al. Malignant hyperthermia and sevoflurane—a case report. Anaesthesiol Intensivmed Notfallmed Schmerzther 1997; 32:641644.

    • Search Google Scholar
    • Export Citation
  • 21.

    Hsu SC, Huang WT, Yen HM, et al. Suspected malignant hyperthermia during sevoflurane anesthesia. J Chin Med Assoc 2007; 70:507510.

  • 22.

    Kinouchi K, Okawa M, Fukumitsu K, et al. Two pediatric cases of malignant hyperthermia caused by sevoflurane. Masui 2001; 50:12321235.

  • 23.

    Schuster F, Metterlein T, Negele S, et al. Intramuscular injection of sevoflurane detects malignant hyperthermia predisposition in susceptible pigs. Anesthesiology 2007; 107:616620.

    • Search Google Scholar
    • Export Citation
  • 24.

    Bagshaw RJ, Cox RH, Knight DH, et al. Malignant hyperthermia in a Greyhound. J Am Vet Med Assoc 1978; 172:6162.

  • 25.

    Murphy JM, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am J Roentgenol 1996; 167:847849.

    • Search Google Scholar
    • Export Citation
  • 26.

    Mair AR, Woolley J, Martinez M. Cardiovascular effects of intravenous gadolinium administration to anaesthetized dogs under magnetic resonance imaging. Vet Anaesth Analg 2010; 37:337341.

    • Search Google Scholar
    • Export Citation
  • 27.

    Roberts MC, Mickeleson JR, Patterson EE, et al. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel. Anesthesiology 2001; 95:716725.

    • Search Google Scholar
    • Export Citation
  • 28.

    Short CE, Paddleford RR. Malignant hyperthermia in the dog (lett). Anesthesiology 1973; 39:462463.

  • 29.

    Rand JS, O'Brien PJ. Exercise-induced malignant hyperthermia in an English Springer Spaniel. J Am Vet Med Assoc 1987; 190:10131014.

  • 30.

    Cohen CA. Malignant hyperthermia in a Greyhound (lett). J Am Vet Med Assoc 1978; 172:1254, 1256.

  • 31.

    Bjodvedt G, Hendricks GM, Weems CW. Exertional rhabdomyolysis in a racing Greyhound. Vet Med Small Anim Clin 1983; 78:12151220.

  • 32.

    Braud KG. Endogenous causes of myopathies in dogs and cats. Vet Med 1997; 92:618628.

  • 33.

    Leary SL, Manning PJ, Bache RJ, et al. Recurrent malignant hyperthermia in a Greyhound. J Am Vet Med Assoc 1983; 182:521522.

  • 34.

    Cosgrove S, Eisele P, Martucci R, et al. Evaluation of Greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures. Lab Anim Sci 1992; 42:482485.

    • Search Google Scholar
    • Export Citation
  • 35.

    Court MH. Anesthesia of the sighthound. Clin Tech Small Anim Pract 1999; 14:3843.

  • 36.

    Wappler F. Anesthesia for patients with a history of malignant hyperthermia. Curr Opin Anaesthesiol 2010; 23:417422.

  • 37.

    McGrath CJ, Rempel WE, Addis PB, et al. Acepromazine and droperidol inhibition of halothane induced malignant hyperthermia (porcine stress syndrome) in swine. Am J Vet Res 1981; 42:195198.

    • Search Google Scholar
    • Export Citation
  • 38.

    Gronert GA, Milde JH. Variations in onset of swine malignant hyperthermia. Anesth Analg 1981; 60:499503.

Advertisement

Anesthesia Case of the Month

Amandeep S. Chohan BVSc & AH, MVSc, MS1 and Stephen A. Greene DVM, MS, DACVA2
View More View Less
  • 1 Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164.
  • | 2 Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164.
History

A 9.5-year-old 20.8-kg (45.8-lb) spayed female Border Collie was referred to the Washington State University Veterinary Teaching Hospital for evaluation of excessive and uncontrollable panting. According to the owner, the panting had begun suddenly 2 nights before with no obvious cause. The dog had had a heart murmur for 2 years for which it had been prescribed enalapril (10 mg, PO, q 24 h). The referring veterinarian obtained 2 radiographic views of the thorax to rule out congestive heart failure, but did not notice any radiographic abnormalities, and the dog was subsequently referred to the cardiology service at the

Contributor Notes

The authors thank Dr. Tamara Grubb for assistance with manuscript preparation.

Address correspondence to Dr. Chohan (Chohan@vetmed.wsu.edu).